levels decline with age, contributing to slower recovery and visible aging
Thus, considering BPC 157/Parkinsons disease/Alzheimers disease, BPC 157 therapy was effective in Parkinsons disease models, and it counteracted parkinsonogenic neurotoxin MPTP-induced tremor, rigor, akinesia, and gastric lesions and counteracted mortality in mice, reserpine-induced akinesia, catalepsy, hypothermia, and catalepsy induced by neuroleptics or NOS-blocker L-NAME application [198,199,200]
Targeting recovery, sleep, focus, longevity, or that lit-from-within glow, our physician-led protocols are built for your goal
Since it mimics a peptide already produced by the body, it's generally considered safe for short- or long-term use
Properties of TB-500 Molecular Formula: C212H350N56O78S Synonym: Thymosin beta4, Thymosin beta4 Acetate, TB500, TB 500, Thymosin beta(4) IUPAC Name : (2S,5S,8S,11S,14S,17S,20S)-2-(3-amino-3-oxopropyl)-14,17-bis(4-aminobutyl)-8-(2-carboxyethyl)-5,11-bis((R)-1-hydroxyethyl)-20-isobutyl-4,7,10,13,16,19,22-heptaoxo-3,6,9,12,15,18,21-heptaazatricosanoic acid Molecular weight: 888.49 g/mol CAS Number: 885340-08-9 PubChem CID: 45382195 Shelf Life: 36 months Properties of BPC-157 Molecular Formula: CHNO Synonyms: BPC157, BPC 157, Bepecin, 8ED8NXK95P, Bpc 15, PLD-116, PL-14736, pl-10, Body protection compound 15 IUPAC Name : (4S)-4-[(2-aminoacetyl)amino]-5-[(2S)-2-[(2S)-2-[(2S)-2-[[2-[[(2S)-6-amino-1-[(2S)-2-[[(2S)-1-[[2-[[(2S)-1-[[(1S)-1-carboxy-2-methylpropyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-2-oxoethyl]carbamoyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-5-oxopentanoic acid
Home Shop Research Guides Calculator About FAQ Cart Welcome to Advance Peptides
